Brain insulin resistance in neurological disorders of various genesis: current state and treatment approaches

Capa

Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

Nowadays, the phenomenon insulin resistance (IR) has expanded and include not only peripheral, but also central IR. However, the underlying mechanisms and physiological manifestations in the central nervous system differ from those on the periphery, and currently the concept of central IR has undergone significant changes. There are abundant evidences of the development of the nervous tissue weakened response to insulin, which directly or indirectly mediates the etiology and pathogenesis of many neurological disorders. Some molecular mechanisms underlying the decrease in the sensitivity of neurons and glial cells to insulin entering from the bloodstream to the central nervous system have been deciphered. This review is devoted to the analysis of the brain IR mechanisms in mental disorders, ischemic and traumatic brain injuries, anesthesia and postoperative stress, as well as cognitive deficits, including those associated with Alzheimer’s disease. Approaches to the diagnosis and treatment of pathological brain conditions caused by central IR are also discussed.

Texto integral

Acesso é fechado

Sobre autores

I. Zorina

Sechenov Institute of Evolutionary Physiology and Biochemistry of the Russian Academy of Sciences

Autor responsável pela correspondência
Email: zorina.inna.spb@gmail.com
Rússia, Saint Petersburg

A. Shpakov

Sechenov Institute of Evolutionary Physiology and Biochemistry of the Russian Academy of Sciences

Email: zorina.inna.spb@gmail.com
Rússia, Saint Petersburg

Bibliografia

  1. Shpakov A.O., Derkach K.V., Berstein L.M. // Future Sci. OA. 2015. V. 1. № 1(3). P. FSO25.
  2. Shpakov A.O., Zorina I.I., Derkach K.V. // Int. J. Mol. Sci. 2023. V. 24. № 4. P. 3278.
  3. Lozinski E., Frohlich L.J. // Edinb. Med. J. 1942. V. 49. № 2. P. 137.
  4. Rhea E.M., Banks W.A, Raber J. // Biomedicines. 2022. V. 10. № 7. P. 1582.
  5. Chan K., Wong F.S., Pearson J.A. // Front. Endocrinol. (Lausanne). 2022. V. 202213. P. 920261.
  6. Chen W., Cai W., Hoover B., Kahn C.R. // Trends Neurosci. 2022. V. 45. № 5. P. 384–400.
  7. Agrawal R., Reno C.M., Sharma S., Christensen C., Huang Y., Fisher S.J. // Am. J. Physiol.-Endoc. M. 2021. V. 321 № 1. P. E156–E163.
  8. Scherer T., Sakamoto K., Buettner C. // Nat. Rev. Endocrinol. 2021. V. 17. № 8. P. 468–483.
  9. Hölscher C. // Expert Opin. Investig. Drugs. 2020. V. 29. № 4. P. 333–348.
  10. Bhusal A., Rahman M.H., Suk K. // Cell. Mol. Life Sci. 2021. V. 79. № 1. P. 32.
  11. Ghowsi M., Qalekhani F., Farzaei M.H., Mahmudii F., Yousofvand N., Joshi T. // BioMedicine. 2021. V. 11. P. 13–22.
  12. Milstein J.L., Ferris H.A. // Mol. Metab. 2021. V. 52. P. 101234.
  13. Pomytkin I., Pinelis V. // Life (Basel). 2021. V. 22. № 11(3). P. 262.
  14. Hallschmid M. // J. Neuroendocrinol. 2021. V. 33. № 4. P. e12934.
  15. Rhea E.M., Banks W.A. // Front. Neurosci. 2019. V. 13. P. 521.
  16. Beddows C.A., Dodd G.T. // J. Neuroendocrinol. 2021. V. 33. P. e12947.
  17. Gray S.M., Barrett E.J. // Am. J. Physiol. Cell Physiol. 2018. V. 315. № 2. P. C125–C136.
  18. Kern W., Benedict C., Schultes B., Plohr F., Moser A., Born J., Fehm H.L., Hallschmid M. // Diabetologia. 2006. V. 49. № 11. P. 2790–2792.
  19. Heni M., Schöpfer P., Peter A., Sartorius T., Fritsche A., Synofzik M., Häring H.U., Maetzler W., Hennige A.M. // Acta Diabetol. 2014. V. 51. № 4. P. 679–681.
  20. Sartorius T., Peter A., Heni M., Maetzler W., Fritsche A., Häring H.U., Hennige A.M. // PLoS One. 2015. V. 12. № 10(5). P. e0126804.
  21. Kullmann S., Valenta V., Wagner R., Tschritter O., Machann J., Häring H.U., Preissl H., Fritsche A., Heni M. // Nat. Commun. 2020. V. 15. № 11(1). P. 1841.
  22. Dakic T., Jevdjovic T., Lakic I., Ruzicic A., Jasnic N., Djurasevic S., Djordjevic J., Vujovic P. // Int. J. Mol. Sci. 2023. V. 24. № 7. P. 6586.
  23. Pertseva M.N., Shpakov A.O. // J. Evol. Biochem. Physiol. 2002. V. 38. P. 547–561.
  24. White M.F., Kahn C.R. // Mol. Metab. 2021. V. 52. P. 101304.
  25. Fruman D.A., Chiu H., Hopkins B.D., Bagrodia S., Cantley L.C., Abraham R.T. // Cell. 2017. V. 10. № 170(4). P. 605–635.
  26. Sharma M., Dey C.S. // Cell Mol. Life Sci. 2021. V. 78. № 23. P. 7873–7898.
  27. Koepsell H. // Pflugers Arch. 2020. V. 472. № 9. P. 1299–1343.
  28. Rangaraju V., Calloway N., Ryan T.A. // Cell. 2014. V. 156. P. 825–835.
  29. Piroli G.G., Grillo C.A., Hoskin E.K., Znamensky V., Katz E.B., Milner T.A., McEwen B.S., Charron M.J., Reagan L.P. // J. Comp. Neurol. 2002. V. 452. P. 103–114.
  30. Sharma M., Yadav Y., Dey C.S. // J. Endocrinol. 2023. V. 260. № 1. P. e230151.
  31. Bakke J., Haj F.G. // Semin. Cell Dev. Biol. 2015. V. 37. P. 58–65.
  32. Thomas M.P., Erneux C., Potter B.V. // Chembiochem. 2017. V. 18. № 3. P. 233–247.
  33. Valencia M., Kim S.R., Jang Y., Lee S.H. // Biomol. Ther. 2021. V. 29. № 6. P. 605–614.
  34. Zakharova I.O., Bayunova L.V., Avrova D.K., Avrova N.F. // J. Evol. Biochem. Phys. 2024. V. 60. P. 57–71.
  35. Zakharova I.O., Sokolova T.V., Bayunova L.V., Zorina I.I., Rychkova M.P., Shpakov A.O., Avrova N.F. // Int. J. Mol. Sci. 2019. V. 20. № 15. P. 3702.
  36. Duarte A.I., Proença T., Oliveira C.R., Santos M.S., Rego A.C. // Diabetes. 2006 V. 55. № 10. P. 2863–2870.
  37. Lioutas V.A., Alfaro-Martinez F., Bedoya F., Chung C.C., Pimentel D.A., Novak V. // Transl. Stroke Res. 2015. V. 6. № 4. P. 264–275.
  38. Roger L.J., Fellows R.E. // Endocrinol. 1980. V. 106. № 2. P. 619–625.
  39. Schubert M., Brazil D.P., Burks D.J., Kushner J.A., Ye J., Flint C.L., Farhang-Fallah J., Dikkes P., Warot X.M., Rio C., Corfas G., White M.F. // J. Neurosci. 2003. V. 6. № 23(18). P. 7084–7092.
  40. Réthelyi J.M., Vincze K., Schall D., Glennon J., Berkel S. // Neurosci. Biobehav. Rev. 2023. V. 153. P. 105330.
  41. Lee C.C., Huang C.C., Hsu K.S. // Neuropharmacol. 2011. V. 61. P. 867–879.
  42. Nemoto T., Yanagita T., Satoh S., Maruta T., Kanai T., Murakami M., Wada A. // Neurochem. Int. 2011. V. 59. P. 880–888.
  43. de Bartolomeis A., De Simone G., De Prisco M., Barone A., Napoli R., Beguinot F., Billeci M., Fornaro M. // Mol. Psych. 2023. V. 28. № 7. P. 2811–2825.
  44. Adzovic L., Domenici L. // J. Neurochem. 2014. V. 131. № 5. P. 582–587.
  45. Trujeque-Ramos S., Castillo-Rolón D., Galarraga E., Tapia D., Arenas-López G., Mihailescu S., Hernández-López S. // Front. Neurosci. 2018. V. 12. P. 345.
  46. Fiory F., Perruolo G., Cimmino I., Cabaro S., Pignalosa F.C., Miele C., Beguinot F., Formisano P., Oriente F. // Front. Neurosci. 2019. V. 13. P. 868.
  47. Martin H., Bullich S., Guiard B.P., Fioramonti X. // J. Neuroendocrinol. 2021. V. 33. № 4. P. e12928.
  48. Kovacs P., Hajnal A. // Neuropeptides. 2009. V. 43. № 4. P. 283–293.
  49. Talbot K., Wang H.Y., Kazi H., Han L.Y., Bakshi K.P., Stucky A., Fuino R.L., Kawaguchi K.R., Samoyedny A.J., Wilson R.S., Arvanitakis Z., Schneider J.A., Wolf B.A., Bennett D.A., Trojanowski J.Q., Arnold S.E. // J. Clin. Invest. 2012. V. 122. № 4. P. 1316–1338.
  50. Colagiuri S., Miller J. // Eur. J. Clin. Nutr. 2002. V. 56 (Suppl 1). P. S30–S35.
  51. Torsoni M.A., Carvalheira J.B., Pereira-Da-Silva M., de Carvalho-Filho M.A., Saad M.J., Velloso L.A. // Am. J. Physiol. Endocrinol. Metab. 2003. V. 285. № 1. P. E216–E323.
  52. Rifkin R.F., Potgieter M., Ramond J.B., Cowan D.A. // Evol. Appl. 2017. V. 10. P. 949–964.
  53. Romanatto T., Cesquini M., Amaral M.E., Roman E.A., Moraes J.C., Torsoni M.A., Cruz-Neto A.P., Velloso L.A. // Peptides. 2007. V. 28. № 5. P. 1050–1058.
  54. van der Crabben S.N., Allick G., Ackermans M.T., Endert E., Romijn J.A., Sauerwein H.P. // J. Clin. Endocrinol. Metab. 2008. V. 93. № 2. P. 638–641.
  55. Brüning J.C., Gautam D., Burks D.J., Gillette J., Schubert M., Orban P.C., Klein R., Krone W., Müller-Wieland D., Kahn C.R. // Science. V. 289. № 5487. P. 2122–2125.
  56. Koch L., Wunderlich F.T., Seibler J., Könner A.C., Hampel B., Irlenbusch S., Brabant G., Kahn C.R., Schwenk F., Brüning J.C. // J. Clin. Invest. 2008. V. 118. P. 2132– 2147.
  57. Kleinridders A., Cai W., Cappellucci L., Ghazarian A., Collins W.R., Vienberg S.G., Pothos E.N., Kahn C.R. // Proc. Natl. Acad. Sci. U S A. 2015. V. 17. № 112(11). P. 3463–3468.
  58. Soto M., Cai W., Konishi M., Kahn C.R. // Proc. Natl. Acad. Sci. USA. 2019. V. 116. № 13. P. 6379–6384.
  59. Grillo C.A., Piroli G.G., Lawrence R.C., Wrighten S.A., Green A.J., Wilson S.P., Sakai R.R., Kelly S.J., Wilson M.A., Mott D.D., Reagan L.P. // Diabetes. 2015. V. 64. № 11. P. 3927–3936.
  60. Schubert M., Gautam D., Surjo D., Ueki K., Baudler S., Schubert D., Kondo T., Alber J., Galldiks N., Küstermann E., Arndt S., Jacobs A.H., Krone W., Kahn C.R., Brüning J.C. // Proc. Natl. Acad. Sci. USA. 2004. V. 2. № 101(9). P. 3100–3105.
  61. Liu Y., Liu F., Grundke-Iqbal I., Iqbal K., Gong C.X. // J. Pathol. 2011. V. 225. P. 54–62.
  62. Anhê G.F., Caperuto L.C., Pereira-Da-Silva M., Souza L.C., Hirata A.E., Velloso L.A., Cipolla-Neto J., Carvalho C.R. // J. Neurochem. 2004. V. 90. P. 559–566.
  63. Faria J.A., Kinote A., Ignacio-Souza L.M., de Araújo T.M., Razolli D.S., Doneda D.L., Paschoal L.B., Lellis-Santos C., Bertolini G.L., Velloso L.A., Bordin S., Anhê G.F. // Am. J. Physiol. 2013. V. 305. P. 230–242.
  64. Shen S., Liao Q., Wong Y.K., Chen X., Yang C., Xu C., Sun J., Wang J. // Int. J. Biol. Sci. 2022. V. 1. № 18(3). P. 983–994.
  65. Verdile G., Keane K.N., Cruzat V.F., Medic S., Sabale M., Rowles J., Wijesekara N., Martins R.N., Fraser P.E., Newsholme P. // Mediators Inflamm. 2015. V. 2015. P. 105828.
  66. Vinuesa A., Pomilio C., Gregosa A., Bentivegna M., Presa J., Bellotto M., Saravia F., Beauquis J. // Front. Neurosci. 2021. V. 23. № 15. P. 653651.
  67. Schell M., Chudoba C., Leboucher A., Alfine E., Flore T., Ritter K., Weiper K., Wernitz A., Henkel J., Kleinridders A. // Nutrients. 2020. V. 23. № 12(5). P. 1518.
  68. Perreault M., Marette A. // Nat. Med. 2001. V. 7. P. 1138–1143.
  69. Katashima C.K., Silva V.R.R., Lenhare L., Marin R.M., Carvalheira J.B.C. // Sci. Rep. 2017. V. 23. № 7(1). P. 9265.
  70. Lennicke C., Cochemé H.M. // Redox Biol. 2021. V. 42. P. 101964.
  71. Maciejczyk M., Żebrowska E., Chabowski A. // Int. J. Mol. Sci. 2019. V. 18. № 20(4). P. 874.
  72. Maciejczyk M., Żebrowska E., Zalewska A., Chabowski A. // Oxid. Med. Cell Longev. 2018. V. 2018. P. 6940515.
  73. Kleinridders A., Lauritzen H.P., Ussar S., Christensen J.H., Mori M.A., Bross P., Kahn C.R. // J. Clin. Invest. 2013. V. 123. № 11. P. 4667–4680.
  74. Vancampfort D., Stubbs B., Mitchell A.J., De Hert M., Wampers M., Ward P.B., Rosenbaum S., Correll C.U. // World psychiatry. 2015. V. 14. № 3. P. 339–347.
  75. Mansur R.B., Delgado-Peraza F., Subramaniapillai M., Lee Y., Iacobucci M., Nasri F., Rodrigues N., Rosenblat J.D., Brietzke E., Cosgrove V.E., Kramer N.E., Suppes T., Raison C.L., Fagiolini A., Rasgon N., Chawla S., Nogueras-Ortiz C., Kapogiannis D., McIntyre R.S. // J. Psychiatr. Res. 2021. V. 133. P. 82–92.
  76. McIntyre R.S., Soczynska J.K., Woldeyohannes H.O., Miranda A., Vaccarino A., Macqueen G., Lewis G.F., Kennedy S.H. // Bipolar Disord. 2012. V. 14. № 7. P. 697–706.
  77. Mansur R.B., Ahmed J., Cha D.S., Woldeyohannes H.O., Subramaniapillai M., Lovshin J., Lee J.G., Lee J.H., Brietzke E., Reininghaus E.Z., Sim K., Vinberg M., Rasgon N., Hajek T., McIntyre R.S. // J. Affect. Disord. 2017. V. 207. P. 114–120.
  78. Aftab A., Kemp D.E., Ganocy S.J., Schinagle M., Conroy C., Brownrigg B., D’Arcangelo N., Goto T., Woods N., Serrano M.B., Han H., Calabrese J.R., Gao K. // J. Affect. Disord. 2019. V. 245. P. 957–964.
  79. Gruber J., Hanssen R., Qubad M., Bouzouina A., Schack V., Sochor H., Schiweck C., Aichholzer M., Matura S., Slattery D.A., Zopf Y., Borgland S.L., Reif A., Thanarajah S.E. // Neurosci. Biobehav. Rev. 2023. V. 149. P. 105179.
  80. Areias M.F., Prada P.O. // Behav. Brain Res. 2015. V. 282. P. 209–217.
  81. Kullmann S., Heni M., Hallschmid M., Fritsche A., Preissl H., Häring H.U. // Physiol. Rev. 2016. V. 96. № 4. P. 1169–1209.
  82. Singh M.K., Leslie S.M., Packer M.M., Zaiko Y.V., Phillips O.R., Weisman E.F., Wall D.M., Jo B., Rasgon N. // Horm. Behav. 2019. V. 108. P. 73–83.
  83. Yang W., Zheng L., Zheng B., Zeng S., Li J., Liang B., Zhu J., Zhang M. // Psychiatr. Danub. 2020. V. 32. P. 46–54.
  84. Thomas E.H.X., Bozaoglu K., Rossell S.L., Gurvich C. // Neurosci. Biobehav. Rev. 2017. V. 77. P. 369–387.
  85. Müller N. // Schizophr. Bull. 2018. V. 44. № 5. P. 973–982.
  86. Boksha I.S., Prokhorova T.A., Savushkina O.K., Tereshkina E.B., Vorobyeva E.A., Burbaeva G.Sh. // Neurochem. J. 2023. V. 17. P. 676–690.
  87. Zhao Z., Ksiezak-Reding H., Riggio S., Haroutunian V., Pasinetti G.M. // Schizophr. Res. 2006. V. 84. P. 1–14.
  88. Chadha R., Meador-Woodruff J. // Schizophr. Bull. 2018. V. 44. P. S400.
  89. Wijtenburg S.A., Kapogiannis D., Korenic S.A., Mullins R.J., Tran J., Gaston F.E., Chen S., Mustapic M., Hong L.E., Rowland L.M. // Schizophr. Res. 2019. V. 208. P. 324–330.
  90. Maldonado J.R. // Int. J. Geriatr. Psychiatry. 2018. V. 33. P. 1428–1457.
  91. Duggan E.W., Carlson K., Umpierrez G.E. // Anesthesiology. 2017. V. 126. № 3. P. 547–560. Erratum in: Anesthesiology. 2018. V. 129. № 5. P. 1053.
  92. Svanfeldt M., Thorell A., Hausel J., Soop M., Nygren J., Ljungqvist O. // Clin. Nutr. 2005. V. 24. P. 815–821.
  93. Chen Y., Run X., Liang Z., Zhao Y., Dai C.L., Iqbal K., Liu F., Gong C.X. // Front. Aging Neurosci. 2014. V. 6. P. 100.
  94. Zhang Y., Dai C.L., Chen, Y., Iqbal K., Liu F., Gong C.X. // Sci. Rep. 2016. V. 6. P. 21186.
  95. Li X., Run X., Wei Z., Zeng K., Liang Z., Huang F., Ke D., Wang Q., Wang J.Z., Liu R., Zhang B., Wang X. // Curr. Alzheimer Res. 2019. V. 16. P. 8–18.
  96. Yu Q., Dai C.L., Zhang Y., Chen Y., Wu Z., Iqbal K., Liu F., Gong C.X. // J. Alzheimers Dis. 2019. V. 70. P. 925–936.
  97. Huang Q., Li Q., Qin F., Yuan L., Lu Z., Nie H., Gong G. // Am. J. Geriatr. Psychiatry. 2021. V. 29. P. 1202–1211.
  98. Bramlett H.M., Dietrich W.D. // J. Cereb. Blood Flow Metab. 2004. V. 24. P. 133–150.
  99. Llompart-Pou J.A., Raurich J.M., Pérez-Bárcena J., Barceló A., Ibáñez J., Ayestarán J.I. // Neurocrit. Care. 2008. V. 9. P. 230–236.
  100. Shaughness M., Acs D., Brabazon F., Hockenbury N., Byrnes K.R. // Front. Neurosci. 2020. V. 14. P. 547175.
  101. Arora P., Singh K., Kumari M., Trivedi R. // Metabolomics. 2022. V. 18. P. 28.
  102. Karelina K., Sarac B., Freeman L.M., Gaier K.R., Weil Z.M. // Eur. J. Neurosci. 2016. V. 43. P. 1034–1043.
  103. Franklin W., Krishnan B., Taglialatela G. // Sci. Rep. 2019. V. 9. P. 8228.
  104. Freeman L.M., Gaier K.R., Weil Z.M. // Eur. J. Neurosci. 2016. V. 43. P. 1034–1043.
  105. Yasmin A., Jokivarsi K., Poutiainen P., Pitkänen A., Gröhn O., Immonen R. // Brain Res. 2022. V. 1788. P. 147934.
  106. Zhou X., Kang C., Hu Y., Wang X. // Front. Public Health. 2023. V. 11. P. 1021378.
  107. Ho L., Qin W., Pompl P.N., Xiang Z., Wang J., Zhao Z., Peng Y., Cambareri G., Rocher A., Mobbs C.V., Hof P.R. // FASEB J. 2004. V. 18. P. 902–904.
  108. Vannucci S.J., Willing L.B., Goto S., Alkayed N.J., Brucklacher R.M., Wood T.L., Towfighi J., Hurn P.D., Simpson I.A. // J. Cereb. Blood Flow Metab. 2001. V. 21. P. 52–60.
  109. Kim B., Sullivan K.A., Backus C., Feldman E.L. // Antioxid. Redox Signal. 2011. V. 14. P. 1829–1839.
  110. Muniyappa R., Chen H., Montagnani M., Sherman A., Quon M.J. // Am. J. Physiol. Endocrinol. Metab. 2020. V. 319. № 3. P. E629–E646.
  111. Sojitra M.H., Garg V.S., Shah K., Joshi S., Vadnagara H., Gandhi S.K., Patel P. // Cureus. 2023. V. 15. № 10. P. e48034.
  112. Nijssen K.M.R., Mensink R.P., Joris P.J. // Neuroendocrinol. 2023. V. 113. № 1. P. 1–13.
  113. Kullmann S., Heni M., Fritsche A., Preissl H. // J. Neuroendocrinol. 2015. V. 27. № 6. P. 419–423.
  114. Weinstein A.M. // Front. Behav. Neurosci. 2023. V. 17. P. 1123733.
  115. Tschritter O., Preissl H., Hennige A.M., Stumvoll M., Porubska K., Frost R., Marx H., Klösel B., Lutzenberger W., Birbaumer N., Häring H.U., Fritsche A. // Proc. Natl. Acad. Sci. 2006. V. 103. № 32. P. 12103–12108.
  116. Tschritter O., Preissl H., Yokoyama Y., Machicao F., Häring H-U., Fritsche A. // Diabetologia. 2007. V. 50. № 12. P. 2602–2603.
  117. Rebelos E., Rinne J.O., Nuutila P., Ekblad L.L. // J. Clin. Med. 2021. V. 10. № 7. P. 1532.
  118. Heni M. // Diabetologia. 2024. V. 67. P. 1181–1191.
  119. Zorina I.I., Avrova N.F., Zakharova I.O., Shpakov A.O. // Biochem. (Mosc). 2023. V. 88. P. 374–391.
  120. Frey W.H. II // US Patent 6,313,093 B1 filed 1999 and issued November 6, 2001.
  121. Schmid V., Kullmann S., Gfrörer W., Hund V., Hallschmid M., Lipp H.P., Häring H.U., Preissl H., Fritsche A., Heni M. // Diabetes Obes. Metab. 2018. V. 20. № 7. P. 1563–1577.
  122. Novak V., Mantzoros C.S., Novak P., McGlinchey R., Dai W., Lioutas V., Buss S., Fortier C.B., Khan F., Aponte Becerra L., Ngo L.H. // J. Neurol. 2022. V. 269. P. 4817–4835.
  123. Zhang H., Hao Y., Manor B., Novak P., Milberg W., Zhang J., Fang J., Novak V. // Diabetes. 2015. V. 64. № 3. P. 1025–1034.
  124. Xu L.B., Huang H.D., Zhao M., Zhu G.C., Xu Z. // Neurocrit. Care. 2021. V. 34. P. 154–166.
  125. Zakharova I.O., Bayunova L.V., Zorina I.I., Sokolova T.V., Shpakov A.O., Avrova N.F. // Int. J. Mol. Sci. 2021. V. 22. P. 11768.
  126. Smith C.J., Sims S-K., Nguyen S., Williams A., McLeod T., Sims-Robinson C. // J. Neurosci. Res. 2023. V. 101. P. 1757–1769.
  127. Sanderson T.H., Kumar R., Murariu-Dobrin A.C., Page A.B., Krause G.S., Sullivan J.M. // Neurol. Res. 2009. V. 31. P. 947–958.
  128. Brabazon F., Wilson C.M., Jaiswal S., Reed J., Frey W.H. Nd., Byrnes K.R. // J. Cereb. Blood Flow Metab. 2017. V. 37. P. 3203–3218.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar
2. Fig. 1. General scheme of signaling pathways activated by insulin and some effects of insulin in the central nervous system and periphery. Abbreviations: INSR/IGF1R – insulin and IGF-1 receptor; IRS – insulin receptor substrate; PI3K – phosphatidylinositol 3-kinase; AKT – serine/threonine-specific protein kinase B (AKT); mTORC1 – mammalian target of rapamycin complex 1; GLUT4 – glucose transporter type 4; GSK3β – glycogen synthase kinase-3β; FOXO1 – transcription factor FOX (forkhead box) family; PKC λ/ζ – protein kinase C λ/ζ-types; eNOS – endothelial NO synthase isoform; MAPK/ERK1/2 – mitogen-activated protein kinase signaling pathway.

Baixar (339KB)
Metadados

Declaração de direitos autorais © Russian Academy of Sciences, 2024